Prudential Financial Inc Mirum Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$19.98 - $29.44 $1.13 Million - $1.67 Million	-56,585 Reduced 34.95%	105,335 $2.21 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $1.5 Million - $2.24 Million	81,620 Added 101.64%	161,920 $3.15 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $252,185 - $389,341	16,270 Added 25.41%	80,300 $1.77 Million
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $835,591 - $1.24 Million	64,030 New	64,030 $1.02 Million

192

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.73B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.